When to switch for antiretroviral treatment failure in resource-limited settings?
When to switch for antiretroviral treatment failure in resource-limited settings?
| dc.contributor.author | Vekemansa, Marc | |
| dc.contributor.author | Johnb, Laurence | |
| dc.contributor.author | Colebunders, Robert | |
| dc.date.accessioned | 2012-05-28T09:21:11Z | |
| dc.date.available | 2012-05-28T09:21:11Z | |
| dc.date.issued | 2007 | |
| dc.description.abstract | Thanks to the leadership of the World Health Organisation (WHO) [1], and massive financial support from programmes such as the Global Fund and the US President’s Emergency Plan for AIDS Relief (PEPFAR), the number of HIV-infected individuals accessing antiretroviral therapy (ART) in resource-limited settings has tripled from 2001 to 2005. An estimated 1.3 million HIV-infected individuals were on ART in 2005, representing 20% of those in need of treatment [2]. | en_US |
| dc.identifier.citation | Vekemansa, M.,John, L.,Colebunders, R. (2007). When to switch for antiretroviral treatment failure in resource-limited settings? AIDS, 21 | en_US |
| dc.identifier.issn | 0269-9370 | |
| dc.identifier.uri | http://hdl.handle.net/10570/591 | |
| dc.language.iso | en | en_US |
| dc.publisher | Lippincott Williams & Wilkins. | en_US |
| dc.subject | Antiretroviral therapy | en_US |
| dc.subject | HIV | en_US |
| dc.subject | Resistance | en_US |
| dc.subject | Switching | en_US |
| dc.subject | Virological failure | en_US |
| dc.subject | CD4+ lymphocyte count | en_US |
| dc.subject | PEPFAR | en_US |
| dc.title | When to switch for antiretroviral treatment failure in resource-limited settings? | en_US |
| dc.type | Journal article, peer reviewed | en_US |